TLDR
- Accenture (ACN) shares declined 4%, reaching a 52-week low near $182 following fiscal 2026 revenue projections ($71.8B–$73.2B) that fell short of analyst expectations around $73.9B.
- The consulting giant exceeded Q2 expectations with earnings per share of $2.93 versus consensus estimates of $2.84, while revenue reached $18.04B, marking a 7.8% increase year-over-year.
- UBS analyst Kevin McVeigh contends investors are overlooking Accenture’s artificial intelligence momentum, noting AI revenue has expanded at a 200% compound annual rate since fiscal 2023.
- The company increased its fiscal 2026 acquisition budget to $5B from a prior $3B target, having already spent $1.6B on strategic purchases like Keepler Data Tech, NeuraFlash, Halfspace, and Decho.
- Microsoft (MSFT), frequently mentioned alongside ACN in AI discussions, has fallen 21% this year and now trades at approximately 22x trailing earnings—its most attractive valuation in nearly ten years.
Shares of Accenture (ACN) began Friday’s session at $186.04 following a 4% decline. The stock touched a new 52-week low, with its annual trading range now spanning from $182.38 to $325.71. The sell-off stems from revenue projections that disappointed market participants.
The company’s leadership provided fiscal 2026 revenue guidance between $71.8 billion and $73.2 billion. Market consensus had anticipated approximately $73.9 billion. This shortfall triggered the stock’s descent to its lowest point in twelve months, despite otherwise robust quarterly performance.
Accenture’s latest quarterly results revealed earnings per share of $2.93, surpassing the $2.84 consensus by nine cents. Revenue totaled $18.04 billion, representing a 7.8% year-over-year increase and exceeding the $17.80 billion projection. The firm’s return on equity registered at 26.33%.
The organization also declared a quarterly dividend distribution of $1.63 per share, scheduled for May 15 payment to shareholders of record on April 9. Based on current trading levels, this represents an annualized yield of 3.5%.
UBS Identifies Mispriced AI Growth Opportunity
UBS analyst Kevin McVeigh released research highlighting what he characterizes as a market valuation error. His analysis focused on Accenture’s recent acquisition of Keepler Data Tech, a Spanish firm that contributes approximately 240 experts specializing in data science, machine learning, and cloud infrastructure.
McVeigh’s central thesis suggests that Accenture’s artificial intelligence initiatives demonstrate greater cohesion and acceleration than current market pricing reflects. From the introduction of generative AI programs in fiscal 2023, the company has expanded AI-related revenues to roughly $2.7 billion by fiscal 2025—representing a compound annual growth rate near 200%. This velocity surpasses even the firm’s initial cloud computing expansion, which achieved approximately 132% growth during comparable early stages.
Accenture elevated its fiscal 2026 acquisition allocation from $3 billion to $5 billion. The corporation has already committed about $1.6 billion toward transactions encompassing NeuraFlash, Halfspace, and Decho. McVeigh interprets this as a strategic pivot toward higher-margin, technology-centric operations away from conventional labor-heavy consulting models.
The firm currently employs over 85,000 AI-specialized professionals. Contract bookings connected to AI and data collaborations are projected to more than double throughout fiscal 2026.
Institutional Trading Activity Continues
Institutional stakeholders maintained active position adjustments in ACN throughout recent reporting periods. Capital International Investors expanded its holdings by 41.1% during Q3, elevating its position to over 17 million shares worth approximately $4.2 billion. Massachusetts Financial Services increased its stake by 12.8%, now controlling roughly 10.1 million shares.
DDD Partners LLC established a fresh position during Q4, purchasing 9,090 shares valued at about $2.44 million.
Institutional and hedge fund holdings currently comprise 75.14% of outstanding shares.
Wall Street analyst sentiment leans cautiously optimistic. Eighteen analysts maintain Buy recommendations on the equity. Ten hold neutral ratings. The consensus price target sits at $274.88, significantly above current trading levels.
The stock’s 50-day moving average currently rests at $210.98 while its 200-day average stands at $241.88. At Friday’s opening, ACN was positioned beneath both technical indicators.
